Home Cart 0 Sign in  

[ CAS No. 348640-06-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 348640-06-2
Chemical Structure| 348640-06-2
Structure of 348640-06-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 348640-06-2 ]

Related Doc. of [ 348640-06-2 ]

Alternatived Products of [ 348640-06-2 ]

Product Details of [ 348640-06-2 ]

CAS No. :348640-06-2 MDL No. :MFCD08272233
Formula : C7H5BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 197.03 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 348640-06-2 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.79
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : 2.0
Log Po/w (WLOGP) : 2.33
Log Po/w (MLOGP) : 1.75
Log Po/w (SILICOS-IT) : 2.75
Consensus Log Po/w : 2.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.99
Solubility : 0.203 mg/ml ; 0.00103 mol/l
Class : Soluble
Log S (Ali) : -2.23
Solubility : 1.16 mg/ml ; 0.0059 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.77
Solubility : 0.0337 mg/ml ; 0.000171 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.49

Safety of [ 348640-06-2 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 348640-06-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 348640-06-2 ]
  • Downstream synthetic route of [ 348640-06-2 ]

[ 348640-06-2 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 55052-24-9 ]
  • [ 348640-06-2 ]
YieldReaction ConditionsOperation in experiment
56% With tetramethylammonium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 0 - 20℃; for 5 h; 1H-pyrrolo[2,3-b]pridine 7-oxide 21 (3.0 g, 22.4 mmol) and tetramethylammonium (4.13 g, 1.2 eq) were dissolved in DMF (30 ml). The Ms2O (7.8 g, 2.0 eq) was added at 0 in small portions. The obtained mixture was stirred for 1 h at 0 and for 4 h at room temperature and diluted with water (60 ml). The PH was adjusted to 7 with solid NaOH, and more than 130 ml of water was added. The resulting suspension was kept at 5 for 1 h. The precipitate was separated by filtration, washed with ice-water (2 * 20 ml), and dried over P2O5 in vacuum oven to give 4-bromo-1H-pyrrolo[2,3-b]pyridine (2.47 g, 56percent). MS (ESI) m/z 196.9 [M+H]+. 1H NMR (400 Hz, CDCl3) δ 10.77 (br, s, 1H), 8.14 (d, J = 5.2 Hz1H), 7.42 (s, 1H), 7.31 (d, J = 5.1 Hz1H), 6.57 (s, 1H).
56% With tetramethylammonium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 0 - 20℃; for 5 h; 1H-7-N-heteroquinone oxynitride 18b (3.0 g, 22.4 mmol),(Me) 4NBr (4.13 g, 1.2 eq) was dissolved in 30 ml of DMF.Cool to 0 ° C,Ms2O (7.8g, 2.0eq) was added in batches,Stir at 0 ° C for 1 h,Stir at room temperature for 4 h, dilute with 60 ml of water.Dilute the NaOH solution to a pH of 7, add 100ml of ice water,Move to -5 ° C, let stand for 1 h, precipitate a solid,Filter under reduced pressure, wash with ice water,Drying in vacuo gave pale yellow powder 18c (2.47 g, 56percent).
55%
Stage #1: With tetrabutylammomium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide; acetonitrile at 0 - 20℃;
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide; acetonitrileCooling with ice
A solution of methanesulfonic anhydride (6.066 g, 34.82 mmol) and acetonitrile (1 1.7 mL) was added by drops to a solution of 1 H-pyrrolo[2,3-b]pyridine 7-oxide (2.333 g, 17.41 mmol), tetramethyl ammonium bromide (4.023 g, 26.12 mmol) in DMF (1 1.7 mL) at O0C. After stirring at O0C for 45 minutes, additional DMF (1 1.7 mL) was added in drops to the thick mixture at 0 0C, and then stirred at room temperature overnight. To the mixture was added ice water (35 mL), followed by 10 N NaOH (-4.66 mL) to pH 7. After stirring at the room temperature, a precipitate formed. It was filtered and washed with water to give 1.891g of 4-bromo-1 H- pyrrolo[2,3-b]pyridine as a pale peach solid (55percent yield). MS (m/z): 197 (MH+). NMR (DMSO- d6) showed 6-9percent impurity which is likely to be the 4,6-dibromo compound based on LC/MS analysis.
53%
Stage #1: With tetramethylammonium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 0 - 20℃;
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide
00298] Step B: Tetramethylammonium bromide (72 g, 470 mmol) was added to IH- pyrrolo[2,3-b]pyridine N-oxide (42 g, 313 mmol) in DMF (500 mL) at 00C, which was followed by addition of methanesulfonic anhydride (109 g, 626 mmol). The suspension was warmed to room temperature and stirred at room temperature for 18 hours. Water (200 mL) was added, and the solution was neutralized with addition of 50percent NaOH. The resulting solution was then further diluted with water (500 mL) and cooled to 00C. The precipitate formed was collected, rinsed with water and diluted in CH2CyMeOH (500 mL, 3:1 v/v). This solution was dried (MgSO4), filtered and concentrated in vacuo to yield 4-bromo-lH-pyrrolo[2,3-b]pyridine (33 g, 53percent yield) as a solid. 1H NMR (400 MHz, (CD3^SO) δ 12.05 (br s, IH), 8.10 (d, IH), 7.61 (dd, IH), 7.34(d, IH), 6.43 (dd, IH); LCMS (APCI+) m/z 196.9, 198.9 (M+H)+, Retention time = 2.59 minutes (Method 1).
45%
Stage #1: With tetrabutylammomium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 0 - 20℃; for 5 h;
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide
1H-pyrrolo[2,3-b]pyridine 7-oxide x257 (3.4 g, 25.4 mmol) and tetramethylammonium bromide (4.7 g, 1.2 eq, 30.4 mmol) are dissolved in DMF (33 ml). Then MS2O (8.8 g, 2 eq, 50.8 mmol) is added at 0 0C in small portions. The obtained mixture is stirred for 1 h at 0 0C, then for 4 h at room temperature, and diluted with water EPO <DP n="162"/>(66 ml). The pH is adjusted to 7 with solid NaOH, and 130 ml more of water is added. The resulting suspension is kept at 5 0C for 1 h. The precipitate is separated by filtration, washed with ice-cold water (2 * 10 ml), and dried over P2O5 under 1 mmHg. The crude sample of x258 (~ 80 percent pure) is purified to the analytically pure state by HPLC to yield 2.2 g of 4-bromo-1 H-pyrrolo[2,3-b]pyridine x258.Yield: 45 percent.LC-MS (MH+): 198.
40% With tetramethylammonium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 20℃; for 18 h; Inert atmosphere [0592] To a stirred solution of tetra methyl ammonium bromide (45 g, 291 mmol) in DMF (182 mL) at 0 °C under an argon atmosphere were added 1H-pyrrolo [2,3-bj pyridine 7- oxide (26 g, 194 mmol) and methane sulfonic anhydride (67.5 g, 388 mmol). The reaction mixture was warmed to room temperature and stirrematerial (by TLC), the reaction mixture was neutralised with 50percent sodium hydroxide solution to pH above 8-9, diluted with water (400 mL) to obtain the solid. The solid was dissolved in 10percentMeOH/CH2C12 (50 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was washed with n-pentane (2 x 50 mL) to afford 4-bromo-1H-pyrrolo [2,3-bj pyridine (15.2 g, 40percent) as an off-white solid. ‘H NMR (DMSO-d6, 500 MHz): 12.01 (br s, 1H), 8.07 (s, 1H), 7.60 (s, 1H), 7.30 (d, 1H), 6.40 (s, 1H), 6.57 (s, 1H); TLC: 5percent MeOH/ CH2C12 (Rj: 0.7).d for 18 h. After consumption of starting
37%
Stage #1: With tetramethylammonium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 0 - 20℃; for 24.5 h; Inert atmosphere
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide
c) To a 3 L fixed vessel under an atmosphere of nitrogen was charged methanesulfonic anhydride (363 g, 2042.71 mmol) portionwise to 1H-pyrrolo[2,3-b]pyridine 7-oxide (137 g, 1021.36 mmol), and tetramethylammonium bromide (236 g, 1532.03 mmol) in DMF (10 vol) (1370 ml) cooled to 0° C. over a period of 30 minutes under nitrogen. The resulting suspension was stirred at 20° C. for 24 hours. The reaction mixture was quenched with water (20 vol, 2740 ml) and the reaction mixture was adjusted to pH 7 with 50percent sodium hydroxide (approx 200 ml). Water (40 vol, 5480 ml) was charged and the mixture cooled to 10° C. for 30 minutes. The solid was filtered, washed with water (20 vol, 2740 ml) and the solid disssolved into DCM/methanol (4:1, 2000 ml), dried over MgSO4 and evaporated to provide a light brown solid. The solid was taken up in hot methanol (2000 ml) and water added dropwise until the solution went turbid and left overnight. The solid was filtered off and discarded, the solution was evaporated and the solid recrystallised from MeCN (4000 ml). The solid was filtered and washed with MeCN to afford 4-bromo-1H-pyrrolo[2,3-b]pyridine (68.4 g, 34percent) as a pink solid; 1H NMR (400 MHz, DMSO-d6) 6.40-6.45 (1H, m), 7.33 (1H, d), 7.57-7.63 (1H, m), 8.09 (1H, t), 12.02 (1H, s); m/z: (ES+) MH+, 198.92. The crude mother liquors were purified by Companion RF (reverse phase C18, 415 g column), using decreasingly polar mixtures of water (containing 1percent NH3) and MeCN as eluents (starting at 26percent upto 46percent MeCN). Fractions containing the desired compound were evaporated to afford 4-bromo-1H-pyrrolo[2,3-b]pyridine (5.4 g, 3percent) as a pink solid; 1H NMR (400 MHz, DMSO-d6) 6.43 (1H, dd), 7.33 (1H, d), 7.55-7.66 (1H, m), 8.09 (1H, d), 12.03 (1H, s); m/z: (ES+) MH+, 199.22.
34.3% With trifluoromethylsulfonic anhydride; tetrabutylammomium bromide In N,N-dimethyl-formamide at 0 - 20℃; A solution of trifluoromethyl sulfonic anhydride (9.3 g, 33 mmol) was added dropwise to a mixture of lH-pyrrolo[2,3- δ]pyridine 7-oxide (3 g, 22 mmol) and tetrabutyl ammonium bromide (10.8 g, 33 mmol) in Λ/,Λ/-dimethylformamide (30 mL) at 0 0C. The resulting mixture was stirred at 00C for 4 h and at room temperature overnight. The reaction was quenched with water and neutralized with IN sodium hydroxide to pΗ=7. The resulting mixture was extracted twice with a mixture of methylene chloride and z-propanol (30 mL, Vm:Vp = 4:1). The organic layer was combined, dried over anhydrous sodium sulfate, concentrated and purified by a reverse- phase preparatory HPLC (0-30 percent: acetonitrile + 0.1 percent TFA in water + 0.1 percent TFA, over 15 min.) to give the title compound (1.5 g, 34.3 percent yield). MS(ESI) m/z 196.8 [M+l]+, 198.8 [M+3]+.
23% With tetrabutylammomium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 25℃; for 4 h; To a 0 0C solution of 7-azaindole-N-oxide (3 g, 22.4 mmol) and tetrabutylammonium bromide (1 1 g, 33.6 mmol) in DMF (37 mL) was added dropwise a solution of methanesulfonic anhydride (5.9 g, 33.6 mmol) in DMF (10 mL). After 4h warming to 25 °C, the solution was added to H2O (50 mL) then neutralized using 1 N NaOH. The resulting precipitate was filtered, stirred in DCM at 0°C for 0.5h and filtered affording the title compound (1 g, 23percent) as a pale white solid: LCMS (m/e) 198 (M+H)+.
21% With tetramethylammonium bromide; methanesulfonic anhydride In N,N-dimethyl-formamide at 0 - 20℃; for 5.5 h; The 1/-/-pyrrolo[2,3-b]pyridine 7-oxide (3.67 g) and tetramethylammonium bromide (1.5 eq.) were placed in DMF (15 ml). The mixture was cooled to 0°C and methanesulfonic anhydride (2 eq.) was added portion wise. The suspension was allowed to reach RT and stirred for 5.5 hours. The reaction mixture was then poured into water (70 ml) and neutralized with 4M NaOH. Water (60 ml) was added. The product was extracted with DCM, washed with water, dried over MgSO4, filtered. The solvent was evaporated and the residue was purified by flash chromatography on silica gel (DCM to DCM/MeOH 9:1 ) to give the 4-bromo-1 H-pyrrolo[2,3-b]pyridine as a yellow oil (21 percent yield).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1208 - 1212
[2] Patent: CN101921268, 2016, B, . Location in patent: Paragraph 0257; 0265-0268
[3] Patent: WO2010/30727, 2010, A1, . Location in patent: Page/Page column 120
[4] Organic Letters, 2003, vol. 5, # 26, p. 5023 - 5025
[5] Patent: WO2009/140320, 2009, A1, . Location in patent: Page/Page column 86
[6] Patent: WO2006/128692, 2006, A2, . Location in patent: Page/Page column 160; 161
[7] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 8, p. 2244 - 2248
[8] Patent: WO2017/31325, 2017, A1, . Location in patent: Paragraph 0592
[9] Patent: US2011/306613, 2011, A1, . Location in patent: Page/Page column 23
[10] Patent: WO2010/62571, 2010, A1, . Location in patent: Page/Page column 125
[11] Patent: WO2007/76423, 2007, A2, . Location in patent: Page/Page column 54
[12] Patent: WO2007/42321, 2007, A2, . Location in patent: Page/Page column 50
[13] ACS Combinatorial Science, 2015, vol. 17, # 1, p. 5 - 10
[14] Patent: WO2006/124863, 2006, A2, . Location in patent: Page/Page column 25
  • 2
  • [ 55052-24-9 ]
  • [ 7143-01-3 ]
  • [ 348640-06-2 ]
YieldReaction ConditionsOperation in experiment
55%
Stage #1: With tetramethylammonium bromide In N,N-dimethyl-formamide; acetonitrile at 0 - 20℃;
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide; acetonitrile
Preparation of 1-methyl-4-phenyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde (Formula 17); A solution of 70percent mCPBA (11.54 g, 66.87 mmole) in ethyl acetate (25 mL) was added by drops to a solution of 7-azaindole (Formula 11, 5 g, 42.3 mmole) in ethyl acetate (40 mL) at 0° C. with a good stirrer. After addition was completed, the mixture was stirred at room temperature for 1 to 2 hours until no starting material left. The mixture was cooled, filtered, and washed with ethyl acetate to give a solid. It was dissolved in 50 mL of water and treated with 30percent K2CO3 solution (16 mL) to pH 9.5-10.5 to give a precipitate. It was stirred at room temperature for 1 hour, cooled, filtered, and washed with a small amount of cold water to give 2.484 g of 1H-pyrrolo[2,3-b]pyridine 7-oxide as a white crystal (Formula 12, 43.8percent yield). MS (m/z): 135.1 (MH+).A solution of methanesulfonic anhydride (6.066 g, 34.82 mmole) and acetonitrile (11.7 mL) was added by drops to a solution of 1H-pyrrolo[2,3-b]pyridine 7-oxide (Formula 12, 2.333 g, 17.41 mmole), tetramethyl ammonium bromide (4.023 g, 26.12 mmole) in DMF (11.7 mL) at 0° C. After stirring at 0° C. for 45 min, additional DMF (11.7 mL) was added in drops to the thick mixture at 0° C., and then stirred at room temperature overnight. To the mixture was added ice water (35 mL), followed by 10 N NaOH (4.66 mL) to pH 7. After stirring at the room temperature, a precipitate formed. It was filtered and washed with water to give 1.891 g of 4-bromo-1H-pyrrolo[2,3-b]pyridine as a pale peach solid (Formula 13, 55percent yield). MS (m/z): 197 (MH+). NMR (DMSO-d6) showed 69percent impurity which is likely to be the 4,6-dibromo compound based on LC/MS analysis.A mixture of 4-bromo-1H-pyrrolo[2,3-b]pyridine (Formula 13, 197 mg, 1 mmole), dimethylamine hydrochloride (88 mg, 1.079 mmole), and paraformaldehyde (33 mg, 1.1 mmole) in n-butanol (2 mL) was heated at 120° C. for 1.25 hours. After removal of the solvent, the residue was treated with ice water and three drops of con. HCl. After washing with ether, the aqueous layer was basified with sat. K2CO3 solution and extracted with methylene chloride. The organic layer was dried over sodium sulfate, filtered, and the solvent dried to give 106 mg of 1-(4-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine as a light pink solid (Formula 14, 42percent). MS (m/z): 254.2 (MH+).A solution of 1-(4-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine (Formula 14, 341 mg, 1.34 mmole) and hexamethylenetetramine (190 mg, 1.34 mmole) in 66percent propionic acid was added by drops to a refluxing solution of hexamethylenetetramine (190 mg, 1.34 mmole) in 66percent propionic acid (0.8 mL) at 120° C. The reaction mixture was heated for 2-4 hours, and monitored by MS. It was cooled, treated with water (4 mL), and filtered to give 238 mg of 4-bromo-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde as a beige solid (Formula 15, 79percent). MS (m/z): 225.0 (MH+).Sodium hydride (60percent, 27.4 mg, 0.686 mmole) was added in portions to a suspension of 4-bromo-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde (Formula 15, 128.6 mg, 0.572 mmole) in 5 mL of DMF and 1 mL of THF at 0° C. After stirring at 0° C. for 20 min, methyl iodide (39.2 μL, 0.6292 mmole) was added by drops into the mixture and warmed up to room temperature for 2.5 hours. The solvents were evaporated and the residue was treated with methylene chloride, filtered, and dried. This was further treated with hexane. The mixture was filtered again and washed with hexane to give a beige solid, which was recrystallized from chloroform and hexane to yield 102 mg of 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde as crystals (Formula 16, 74percent). MS (ESI): m/z 239 (M+H).A mixture of 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde (Formula 16, 38 mg, 0.159 mmole), phenyl boronic acid (38.8 mg, 0.318 mmole), and tetrakis(triphenylphosphine)palladium (0) (27.6 mg, 0.0238 mmole) in saturated sodium carbonate (0.37 mL) and 1,2-dimethoxylethane (1.4 mL) was heated at 120° C. in microwave for 20 min. It was filtered through a pad of silica gel and washed with 5percent MeOH in ethyl acetate. After the solvent was evaporated, acetonitrile was added to the residue, and filtered to remove a bright yellow solid. The filtrate was concentrated to yield 51.4 mg of 1-methyl-4-phenyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde as white crystals (Formula 17, Ar=phenyl, 76percent). MS (ESI): m/z 237(M+H).
47% With tetrabutylammomium bromide In N,N-dimethyl-formamide at 0 - 20℃; for 4.5 h; 1H- Pyrrolo[2,3-b]pyridine oxide (50 g, 373 mmol) and tetramethylammonium bromide (86 g, 559 mmol) were stirred into DMF (500 ml_) at room temperature and then cooled to 0 0C. Methanesulphonic anhydride was then run into the stirred mixture over about half an hour. Stirring was continued for a further 4 h during which time the reaction warmed to rt. This mixture was then poured onto water (1 L) with stirring and carefully neutralised (pH = 7) by the addition of sodium hydroxide solution. A further amount of water was added (1.5 L) followed by ice so that the temperature of the stirred suspension was reduced to about 10 0C. The solid was then removed by filtration and washed with ice/water. The solid was dried in the air and then stirred in cold DCM (80 mL) for half an hour before being collected by filtration, washed with a further small amount of DCM and then dried. This gave the product, 4-bromo-7f/-pyrrolo[2,3-b]pyridine as a tan solid (34.55 g, 175.3 mmol, 47percent), mp 173-176 0C, RF 0.45 (EtOAc). HPLC indicated 94-95percent purity.
Reference: [1] Patent: US2009/298820, 2009, A1, . Location in patent: Page/Page column 36-37
[2] Patent: WO2007/76320, 2007, A2, . Location in patent: Page/Page column 37
  • 3
  • [ 55052-24-9 ]
  • [ 1000340-33-9 ]
  • [ 348640-06-2 ]
Reference: [1] Patent: WO2009/126675, 2009, A1, . Location in patent: Page/Page column 128-129
  • 4
  • [ 271-63-6 ]
  • [ 348640-06-2 ]
Reference: [1] Patent: WO2008/49855, 2008, A2, . Location in patent: Page/Page column 50-51
[2] Patent: US2011/306613, 2011, A1,
[3] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1208 - 1212
[4] ACS Combinatorial Science, 2015, vol. 17, # 1, p. 5 - 10
[5] Patent: WO2017/31325, 2017, A1,
[6] Patent: CN101921268, 2016, B,
[7] Patent: WO2006/124863, 2006, A2,
[8] Patent: WO2006/128692, 2006, A2,
[9] Patent: WO2009/140320, 2009, A1,
  • 5
  • [ 348640-06-2 ]
  • [ 640735-23-5 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 26, p. 5023 - 5025
[2] Patent: WO2017/31325, 2017, A1,
  • 6
  • [ 98-59-9 ]
  • [ 348640-06-2 ]
  • [ 348640-07-3 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃; for 2 h;
4-Bromo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine [D003] (0202) 4-Bromo-7-azaindole (3 g, 15.22 mmol) was weighed into a round bottom flask and dissolved in THF (50 mL) under nitrogen. The reaction mixture was cooled to 0° C. and treated portionwise with sodium hydride (60percent in mineral oil, 0.67 g, 16.75 mmol), the addition was accompanied by fizzing. After the addition the reaction mixture was allowed to stir for 30 minutes at room temperature and then treated with benzenesulfonyl chloride (2.14 mL, 16.75 mmol). The reaction mixture was allowed to warm to room temperature and stirred for 2 hours. The reaction mixture was evaporated under reduced pressure and dissolved in DCM 30 mL, the organics were washed with 2×30 mL portions of 2M sodium carbonate, dried with MgSO4, filtered and evaporated to an orange oil. Purified by flash column chromatography eluting with 1:9 ethyl acetate:cyclohexane to provide the title compound as an off white solid (92percent). LCMS method: 5, RT 5.36 min, MI 337 [M+H]; NMR: (1H, 500 MHz, CDCl3) 8.22 (d, 1H), 8.18 (d, 2H), 7.78 (d, 1H), 7.58 (t, 1H), 7.48 (t, 2H), 7.35 (d, 1H), 6.63 (d, 1H).
81% With sodium hydroxide In dichloromethane at 20℃; for 1 h; d) Sodium hydroxide (31.4 ml, 188.35 mmol) was added to 4-bromo-1H-pyrrolo[2,3-b]pyridine (10.03 g, 50.91 mmol), tosyl chloride (19.41 g, 101.81 mmol) and tetrabutylammonium hydrogensulfate (0.519 g, 1.53 mmol) in DCM (250 ml) at RT. The resulting mixture was stirred at RT for 1 hour. The reaction was quenched through the addition of saturated aqueous NH4Cl, the organic layer removed and the aqueous layer further extracted with DCM (3.x.25 ml). The combined organics were washed with brine (100 ml), dried over Na2SO4 and then concentrated under reduced pressure. The residue was purified by flash chromatography on silica, eluting with a gradient of 0 to 20percent EtOAc in isohexane. Pure fractions were evaporated to afford 4-bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine (14.50 g, 81percent); 1H NMR (400 MHz, CDCl3) 2.38 (3H, s), 6.64 (1H, d), 7.28 (2H, d), 7.36 (1H, d), 7.78 (1H, d), 8.06 (2H, d), 8.22 (1H, d); m/z: (ES+) MH+, 353.23.
80% With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane; water at 20℃; for 4 h; Toluenesulfonyl chloride (219.0 g, 1.126 mol) and tetrabutylammonium hydrogen sulphate (9.8 g, 28.0 mmol) were added to a solution of 4-bromo-1 H-pyrrolo[2,3-b]pyridine (which may be prepared as described in Org Letts, 2003, 5, 5023) (1 11.0 g, 0.563 mol) in DCM (2.8 L). To this was then added dropwise over 30 min a solution of sodium hydroxide (67.56 g, 1.59 mol) in water (281.2 mL), and the resultant reaction mixture was stirred at room temperature for 4 h. Water (562 mL) was then added, the organic phase was separated, washed with water (2 x 562 mL), dried (Na2SO4), and the solvent was removed under reduced pressure. The residue was taken up and heated at reflux in hexane twice (1.24 L) before being allowed to cool to room temperature. The resultant precipitate was then collected by filtration, washed with hexane (2 x 570 mL), and dried. It was then allowed to form a slurry in 1 :1 MeOH/water (304 mL) before once again being filtered off, washed with 1 :1 MeOH/water (2 x 304 mL), and dried under vacuum. The process was repeated a further time, with a slurry being formed in hexane (1.14 L), to give 4-bromo-1-[(4-methylphenyl)sulfonyl]-1 H-pyrrolo[2,3-b]pyridine (158.9 g, 80percent) as a brown solid.
70% With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane; water at 20℃; for 0.5 h; Aqueous NaOH (6N, 5 mL) was added to a solution of 4-bromo-1H-pyrrolo[2,3- jpyridine (1.6 g, 8.1 mmol), TsCI (3.1 g, 2.0 mmol) and Bu4NHSO4 (82.7 mg, 0.3 mmol) in CH2CI2 (40 mL). The reaction mixture was stirred at rt for 30 min. After that, the reaction was diluted with saturated aqueous solution of NH4CI, and <n="36"/>extracted with CH2CI2 (2OmL X 3 times). The organic layer was washed by brine, dried over Na2SO4, and then evaporated under reduced pressure. The residue was purified by silica gel chromatography (EtOAc:Hex = 1:4), and the corresponding product was obtained as a white solid (2.0 g, 70 percent). 1H NMR ppm (400MHz, DMSO-d6) 2.35 (s, 3H), 6.79 (d, 1H, J = 4.0 Hz), 7.43 (d,2H, J = 8.1 Hz), 7.61 (d, 1H, J = 5.3 Hz), 8.00 (d, 2H, J= 8.1 Hz), 8.04 (d, 1H, J = 4.0 Hz), 8.25 (d, 1H, J = 5.1 Hz). LC/MS: m/z 351 (M-1)-, 353 (M+2)+
70% With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane; water at 20℃; for 0.5 h; Aqueous NaOH (6N, 5 mL) was added to a solution of 4-bromo-1H-pyrrolo[2,3-b]pyridine (1.6 g, 8.1 mmol), TsCl (3.1 g, 2.0 mmol) and Bu4NHSO4 (82.7 mg, 0.3 mmol) in CH2Cl2 (40 mL).
After stirring the mixture at rt for 30 min, the reaction was quenched by saturated aqueous NH4Cl, and extracted with CH2Cl2 (20 mL*3 times).
The organic layer was washed with brine, dried over Na2SO4, and then evaporated to dryness under reduced pressure.
The residue was purified on a silica gel column (EtOAc:Hex=1:4), and the corresponding product was obtained as a white solid (2.0 g, 70percent).
1H NMR (400 MHz, DMSO-d6) ppm 2.35 (s, 3H), 6.79 (d, 1H, J=4.0 Hz), 7.43 (d, 2H, J=8.1 Hz), 7.61 (d, 1H, J=5.3 Hz), 8.00 (d, 2H, J=8.1 Hz), 8.04 (d, 1H, J=4.0 Hz), 8.25 (d, 1H, J=5.1 Hz). MS (ESI): m/z 351,353 (M+1)+
9.12 g
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil for 0.5 h; Inert atmosphere
Stage #2: for 2.16667 h;
Step A.
4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine (Intermediate 131A-a)
4-Bromo-7-azaindole (5.0 g, 28.90 mmol) was dissolved in DMF (40 mL) and the solution was stirred at RT under a stream of nitrogen.
Sodium hydride (60percent on mineral oil, 1.50 g, 37.58 mmol) was added portion wise and the reaction was stirred for 30 min.
A solution of 4-toluenesulfonyl chloride (5.77 g, 30.37 mmol) in DMF (10 mL) was added dropwise over 10 min, and then the reaction was stirred for a further 2 h.
The reaction mixture was carefully poured into cold water (100 mL) and stirred for 30 min.
The resulting precipitate was collected by filtration and dried in vacuo. the product was obtained as an off-white solid (9.12 g).
LCMS (Method 6): Rt=1.59 min, m/z 351.1/353.1 [M+H]+

Reference: [1] Tetrahedron Letters, 2016, vol. 57, # 42, p. 4718 - 4722
[2] Patent: US2015/274720, 2015, A1, . Location in patent: Paragraph 0202
[3] Patent: US2011/306613, 2011, A1, . Location in patent: Page/Page column 23
[4] Patent: WO2008/145688, 2008, A2, . Location in patent: Page/Page column 42; 89
[5] Patent: WO2007/76320, 2007, A2, . Location in patent: Page/Page column 34-35
[6] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 16, p. 4610 - 4614
[7] Patent: US2009/18156, 2009, A1, . Location in patent: Page/Page column 14
[8] Patent: WO2012/170752, 2012, A1, . Location in patent: Page/Page column 40
[9] Patent: WO2014/139328, 2014, A1, . Location in patent: Page/Page column 454; 455
[10] Patent: US2014/275153, 2014, A1, . Location in patent: Paragraph 0616
[11] Patent: US2015/218165, 2015, A1, . Location in patent: Paragraph 1138
[12] Patent: US2018/215758, 2018, A1, . Location in patent: Paragraph 0467-0468
  • 7
  • [ 73183-34-3 ]
  • [ 348640-06-2 ]
  • [ 942919-26-8 ]
YieldReaction ConditionsOperation in experiment
9.2% at 120℃; for 16 h; Inert atmosphere; Sealed vial Boronic ester 1 : 4-(4,4,5,5-Tetramethyl-[1 ,3,2]dioxa borolan-2-yl)-1 H-pyrrolo[2,3- b]pyridineTo a solution of 4-Bromo-7-azaindole (0.48 g, 2.41 mmol) in dioxane (12 mL) was added bis(pinacolato)diboron followed by bis(diphenylphosphino)ferrocene (0.067 g, 0.12 mmol). The mixture was degassed for 20 minutes using nitrogen, followed by addition of PdCI2(dppf) catalyst (0.088 g, 0.12 mmol). Suspension was degassed for additional 5 minutes. Vial was seal and placed in an oil bath. The reaction was heated to 120 °C for 16 hours. After completion, the reaction mixture was allowed to cool to ambient temperature, suspension was filtered and solvent was removed under reduced pressure. The crude was directly purified on Biotage using 0-100 percent gradient of EtOAC/Heptane. Further purification was done using preparartive HPLC (gradient 5percent-95percent with 3percent n-propanol/acetonitrile over 3percent n- propanol/water) to afford as a white solid (0.054 g, 9.2 percent) LC/MS analysis using method 7, mass (ES+) m/z 245.4 1H NMR (CDCI3) δ 9.03 (1 H, brs), 8.24 (1 H, d), 7.42 (1 H, d), 7.30 (1 H, d), 6.86 (1 H,d), 1 .31 (12H,s)
Reference: [1] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 3973 - 4001
[2] Patent: WO2012/104776, 2012, A1, . Location in patent: Page/Page column 56
  • 8
  • [ 348640-06-2 ]
  • [ 889939-26-8 ]
Reference: [1] Patent: US2015/218165, 2015, A1,
  • 9
  • [ 348640-06-2 ]
  • [ 943323-65-7 ]
Reference: [1] Patent: WO2013/114113, 2013, A1,
[2] Patent: US2015/11533, 2015, A1,
  • 10
  • [ 348640-06-2 ]
  • [ 480423-17-4 ]
Reference: [1] Patent: WO2014/139328, 2014, A1,
[2] Patent: US2014/275153, 2014, A1,
[3] Patent: US2015/218165, 2015, A1,
[4] Tetrahedron Letters, 2016, vol. 57, # 42, p. 4718 - 4722
[5] Patent: WO2008/145688, 2008, A2,
  • 11
  • [ 124-38-9 ]
  • [ 348640-06-2 ]
  • [ 479553-01-0 ]
Reference: [1] Patent: WO2008/144253, 2008, A1, . Location in patent: Page/Page column 28
  • 12
  • [ 348640-06-2 ]
  • [ 1014613-64-9 ]
Reference: [1] Patent: WO2012/170752, 2012, A1,
[2] Patent: WO2012/170752, 2012, A1,
[3] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 15, p. 4344 - 4353
[4] Patent: WO2009/147188, 2009, A1,
  • 13
  • [ 24424-99-5 ]
  • [ 348640-06-2 ]
  • [ 1228014-35-4 ]
YieldReaction ConditionsOperation in experiment
92.1% With dmap; triethylamine In dichloromethane at 0 - 20℃; for 2 h; j0695j To a solution of 4-bromo-1H-pyrrolo[2,3-bjpyridine (XCI) (5 g, 25.4 mmol, 1 eq.), DMAP (311 mg, 2.55 mmol, 0.1 eq.) and TEA (5.3 mL, 38 mmol, 3 eq.) in DCM (100 mL) was added Boc2O (7.2 mL, 31 mmol, 1.2 eq.) at 0°C. The reaction was warmed to room temperature and stirred for 2 h. Water (100 mL) was added and extracted with DCM (x 2). Removal solvents gave tert-butyl 4-bromo-1H-pyrrolo[2,3-bjpyridine-1-carboxylate (XCII) as a colorless oil (6.95 g, 23.4 mmol, 92.1percent yield). ‘H NMR (CDC13, 400 MHz) ppm 1.60 (s, 9H), 6.50 (d, J=4Hz, 1H), 7.31 (d,J=5.2Hz, 1H), 7.63 (d,J=4Hz, 1H), 8.23 (d,J=5.2Hz, 1H); ESIMS found for C,2H,3BrN2O2 mlz 297.1 (M+H).
92.1% With dmap; triethylamine In dichloromethane at 0 - 25℃; for 2 h; To a solution of 4-bromo-lH-pyrrolo[2,3-b]pyridine (LXXIV) (5 g, 25.4 mmol, 1 eq.), DMAP (311 mg, 2.55 mmol, 0.1 eq.) and TEA (5.3 mL, 38 mmol, 3 eq.) in DCM (100 mL) was added B0C2O (7.2 mL, 31 mmol, 1.2 eq.) at 0°C. The reaction was warmed to room temperature and stirred for 2 h. Water (100 mL) was added and extracted with DCM (x 2). Removal solvents gave fert-butyl 4-bromo-lH-pyrrolo[2,3-b]pyridine-l-carboxylate (LXXV) as a colorless oil (6.95 g, 23.4 mmol, 92.1percent yield). NMR (CDCI3, 400 MHz) δ ppm 1.60 (s, 9H), 6.50 (d, J=4Hz, 1H), 7.31 (d, J=5.2Hz, 1H), 7.63 (d, J=4Hz, 1H), 8.23 (d, J=5.2Hz, 1H); ESIMS found for Ci2Hi3BrN202 mlz 297.1 (M+H).
92.1% With dmap; triethylamine In dichloromethane at 0 - 20℃; for 2 h; Step 1 [0676] To a solution of 4-bromo-lH-pyrrolo[2,3-b]pyridine (LXXIV) (5 g, 25.4 mmol, 1 eq.), DMAP (311 mg, 2.55 mmol, 0.1 eq.) and TEA (5.3 mL, 38 mmol, 3 eq.) in DCM (100 mL) was added B0C2O (7.2 mL, 31 mmol, 1.2 eq.) at 0°C. The reaction was warmed to room temperature and stirred for 2 h. Water (100 mL) was added and extracted with DCM (x 2). Removal solvents gave fert-butyl 4-bromo-lH-pyrrolo[2,3-b]pyridine-l-carboxylate (LXXV) as a colorless oil (6.95 g, 23.4 mmol, 92.1percent yield). NMR (CDCI3, 400 MHz) δ ppm 1.60 (s, 9H), 6.50 (d, J=4Hz, 1H), 7.31 (d, J=5.2Hz, 1H), 7.63 (d, J=4Hz, 1H), 8.23 (d, J=5.2Hz, 1H); ESIMS found for Ci2Hi3BrN202 mlz 297.1 (M+H).
92.1% With dmap; triethylamine In dichloromethane at 0 - 20℃; for 2 h; To a solution of 4-bromo-lH-pyrrolo[2,3-b]pyridine (LXXIV) (5 g, 25.4 mmol, 1 eq.), DMAP (311 mg, 2.55 mmol, 0.1 eq.) and TEA (5.3 mL, 38 mmol, 3 eq.) in DCM (100 mL) was added B0C2O (7.2 mL, 31 mmol, 1.2 eq.) at 0°C. The reaction was warmed to room temperature and stirred for 2 h. Water (100 mL) was added and extracted with DCM (x 2). Removal solvents gave fert-butyl 4-bromo-lH-pyrrolo[2,3-b]pyridine-l-carboxylate (LXXV) as a colorless oil (6.95 g, 23.4 mmol, 92.1percent yield). NMR (CDCI3, 400 MHz) δ ppm 1.60 (s, 9H), 6.50 (d, J=4Hz, 1H), 7.31 (d, J=5.2Hz, 1H), 7.63 (d, J=4Hz, 1H), 8.23 (d, J=5.2Hz, 1H); ESIMS found for Ci2Hi3BrN202 mlz 297.1 (M+H).
87% With triethylamine In tetrahydrofuran at 0 - 70℃; Scheme 17: Synthesis of tert-butyl 4-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yI)-lH- pyrrolo[2,3-b]pyridine-l-carboxylate [77] 75 76 77Step 1Compound [75] (1.0 g, 5.1 mmol) was dissolved in THF (30 ml) and the temperature brought down to 0 °C with an ice bath. To this reaction mixture TEA (1.41 ml, 10.2 mmol), followed by BOC anhydride (1.33 g, 6.2 mmol) was added. A catalytic amount of DMAP (50 mg) was then added. This reaction mixture was then allowed to stirred and refluxed under nitrogen at 70°C for 18 h. TLC and mass spectral analysis confirmed completion of the reaction. The reaction mixture was diluted with ethyl acetate (30 ml) which was washed with water and brine solution. The organic layers were combined, dried using anhydrous Na2S04., filtered, and evaporated to yield [76] as a brown solid (1.3 g, 87percent).ESIMS: 298 (M+ +l)
87% With dmap; triethylamine In tetrahydrofuran at 0 - 70℃; Inert atmosphere Step 1 Compound [75] ( 1.0 g, 5. 1 mmol) was dissolved in THF (30 ml) and the temperature brought down to 0 °C with an ice bath. To this reaction mixture TEA ( 1.41 ml, 10.2 mmol), followed by BOC anhydride ( 1.33 g, 6.2 mmol) was added. A catalytic amount of DMAP (50 mg) was then added. This reaction mixture was then allowed to stirred and refluxed under nitrogen at 70°C for 18 h. TLC and mass spectral analysis confirmed completion of the reaction. The reaction mixture was diluted with ethyl acetate (30 ml) which was washed with water and brine solution. The organic layers were combined, dried using anhydrous NaiS04., filtered, and evaporated to yield [76] as a brown solid ( 1.3 g, 87percent). ESIMS: 298 (M+ + 1 )
61% With triethylamine In dichloromethane at 20℃; for 3 h; A mixture of 4-bromo-lH-pyrrolo[2,3-δ]pyridine (250 mg, 1.26 mmol), di-te/t-butyl dicarbonate (302 mg, 1.38 mmol), dimethyl-pyridin-4-yl-amine (7.6 mg, 0.06 mmol) and triethylamine (127 mg, 1.26 mmol) in anhydrous methylene chloride (15 rnL) was stirred at room temperature for 3 h. Upon completion of the reaction as indicated by TLC, the volatiles were removed under reduced pressure and the residue was purified by column chromatography on silica gel (9-25 percent ethyl acetate in petroleum ether) to give the desired product (230 mg, 61 percent yield) as an oil. MS (ESI) m/z 242.9 [M-56+l]+

Reference: [1] Patent: WO2017/24021, 2017, A1, . Location in patent: Paragraph 0694; 0695
[2] Patent: WO2017/24004, 2017, A1, . Location in patent: Paragraph 0676
[3] Patent: WO2017/23980, 2017, A1, . Location in patent: Paragraph 0676
[4] Patent: WO2017/23996, 2017, A1, . Location in patent: Paragraph 0676
[5] Patent: WO2012/101654, 2012, A2, . Location in patent: Page/Page column 59
[6] Patent: WO2014/16849, 2014, A2, . Location in patent: Page/Page column 115
[7] Patent: WO2010/62571, 2010, A1, . Location in patent: Page/Page column 125-126
[8] Organic and Biomolecular Chemistry, 2011, vol. 9, # 14, p. 5129 - 5136
[9] Patent: WO2017/202742, 2017, A1, . Location in patent: Page/Page column 90; 91
  • 14
  • [ 74-88-4 ]
  • [ 348640-06-2 ]
  • [ 1234616-25-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 7, p. 2321 - 2325
  • 15
  • [ 348640-06-2 ]
  • [ 1000340-34-0 ]
Reference: [1] Patent: WO2012/170752, 2012, A1, . Location in patent: Page/Page column 31-32
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 348640-06-2 ]

Bromides

Chemical Structure| 1014613-64-9

[ 1014613-64-9 ]

4-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 1363382-02-8

[ 1363382-02-8 ]

4-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.92

Chemical Structure| 183208-35-7

[ 183208-35-7 ]

5-Bromo-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Chemical Structure| 916176-52-8

[ 916176-52-8 ]

4-Bromo-5-chloro-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.86

Chemical Structure| 74420-15-8

[ 74420-15-8 ]

3-Bromo-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.85

Related Parent Nucleus of
[ 348640-06-2 ]

Other Aromatic Heterocycles

Chemical Structure| 1014613-64-9

[ 1014613-64-9 ]

4-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 1363382-02-8

[ 1363382-02-8 ]

4-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.92

Chemical Structure| 183208-35-7

[ 183208-35-7 ]

5-Bromo-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Chemical Structure| 916176-52-8

[ 916176-52-8 ]

4-Bromo-5-chloro-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.86

Chemical Structure| 74420-15-8

[ 74420-15-8 ]

3-Bromo-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.85